Tissue Regenix Group (TRX)

 

TRX Share PerformanceMore

52 week high22.000 31/05/16
52 week low14.000 19/05/17
52 week change -4.250 (-22.08%)
4 week volume1,626,907 01/05/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Tissue Regenix looks to acquire CellRight

Tissue Regenix Group said it has noted the recent application for a temporary restraining order filed by one of the membe...

Potential Acquisition

RNS Number: 6788F Tissue Regenix Group PLC 19 May 2017 Tissue Regenix Group plc Potential Acquisition Leeds, 19 May 2017 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group") the regenerative medical devices company, notes the recent application for a temporary restraining order ("TRO") filed by one of the members of CellRight Technologie...

Tissue Regenix issues equity

Tissue Regenix Group has today issued and allotted about 1.3m shares of 0.5p each, following an exercise of options which w...

Issue of Equity

RNS Number: 2415B Tissue Regenix Group PLC 03 April 2017 Tissue Regenix Group Plc Issue of equity and total voting rights Leeds, 3 April 2017 - Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix" or "the Company"), the regenerative medical devices company,announces that it has today issued and allotted 1,295,632 ordinary shares of 0.5p each in the Company, ...

Hardman Research: Addressing woundcare in the US

RNS Number: 1719Z Tissue Regenix Group PLC 13 March 2017 Hardman Research: Addressing woundcare in the US Addressing woundcare in the US: TRX has a broad portfolio of regenerative medicine products developed from decellularised human and porcine tissues for the wound care, orthopaedics, and cardiac markets. Sales of DermaPure have continued to ga...

Innovative Technology Contract Awarded

RNS Number: 1394Y Tissue Regenix Group PLC 01 March 2017 Tissue Regenix Group plc Innovative Technology Contract Awarded DermaPure Receives Innovative Technology Contract from Vizient, Inc. Leeds, 01 March 2017 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group"), the regenerative medical devices company, announces effective from...

TRX says DermaPure added to Federal Supply Schedule

Tissue Regenix Group has been included on the US Department of Veteran Affairs (VA) Federal Supply Schedule (FSS) vi...

DermaPure? added to the Federal Supply Schedule

RNS Number: 8102V Tissue Regenix Group PLC 02 February 2017 Tissue Regenix Group plc DermaPure added to the Federal Supply Schedule Leeds, 02 February 2017 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group") the regenerative medical devices company today announces DermaPure a decellularized dermal allograft, utilising Tissue Regen...

Fundamental DataMore

EPS-1.27
Dividend yield0 %

Equity Research (TRX)

hardman & co
Tissue Regenix Group Plc
17/03/2017
TRX has a broad portfolio of regenerative medicine products developed from decellularised human and porcine tissues for the wound care, orthopaedics, and cardiac markets. Sales of DermaPure have...
edison investment research
Tissue Regenix Group Plc
03/02/2017
Edison Investment Research is terminating coverage on Tissue Regenix Group (TRX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should...
edison investment research
Tissue Regenix Group Plc
19/10/2016
Tissue Regenix’s interim results are in line with our expectations and demonstrate the progress the company is making to achieve various milestones in each of its divisions. In particular, its Wound...

Latest discussion posts More

  • Re: Potential acquisition

    Looks like a good move. If memory serves, Tissue Regenix have been working with the CellRight Company for a couple of years and, through them, helped the launch of TRX's ...
    20-May-2017
    ybhere
  • Re: Potential acquisition

    The SP seems to be currently in reverse. Thought there would be more good news from sales. CL
    19-May-2017
    Chicken Lips
  • Potential acquisition

    RNS this morning. Have to wait to see what happens. I suppose we'll have a cash call if it goes ahead ! TP
    19-May-2017
    theprior

Users' HoldingsMore

Users who hold Tissue Regenix Group also hold..
LLOYDS GRP.32%
BP23%
TESCO20%
SIRIUS MINERALS20%
TAYLOR WIMPEY16%

Codes & Symbols

ISINGB00B5SGVL29
SymbolsTRX, LSE:TRX, TRX.L, TRX:LN, LON:TRX, XLON:TRX